Neuroblastoma is an aggressive childhood cancer that occurs in children less than 6 years of age. The first challenge is that 20 percent of children are unable to attain remission. The primary goal of this study is to evaluate the feasibility of using molecular guided therapy in combination with standard chemotherapy to increase response. The second challenge in neuroblastoma is …